As a non pharmacy person I was pondering on the phase 2 trials in train or recently completed. We have been told that the animal trials in all 4 indications were very strong ( followed up by very strong results in the first reported PH2 trial) . Was their a significant difference between the 4 indications results in animal trials? If so , where did Ph-McD ( first p2 results) sit in the order of animal trials?
As a non pharmacy person I was pondering on the phase 2 trials...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.05 |
Change
-1.220(6.02%) |
Mkt cap ! $2.438B | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.50 | $18.92 | $11.98M | 617.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 254 | $19.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.05 | 300 | 8 |
View Market Depth
| Last trade - 14.24pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.04 |
Change
-1.220 ( 6.51 %) |
||||
| Open | High | Low | Volume | ||
| $20.39 | $20.46 | $18.92 | 226663 | ||
| Last updated 14.43pm 04/06/2024 ? | |||||
| NEU (ASX) Chart |